Current management of children and young people with heterozygous familial hypercholesterolaemia - HEART UK statement of care
Uma Ramaswami(The Royal Free Hospital), Andrew A. M. Morris(Newcastle University), Peter Dale(Royal Gwent Hospital), Steve E. Humphries(University College London), David S Wald(Queen Mary University of London), Peter Green(Columbia University), Lorraine Priestley-Barnham(Royal Brompton & Harefield NHS Foundation Trust), Nigel Capps(Princess Royal Hospital), Mark Anderson(Great North Children's Hospital)
Cited by 72
Related Papers
Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: Consensus Statement of the European Atherosclerosis Society
|European Heart Journal|2013|2.7k
<scp>SIMR</scp>: an R package for power analysis of generalized linear mixed models by simulation
|Methods in Ecology and Evolution|2015|2.4k
World Health Organization cardiovascular disease risk charts: revised models to estimate risk in 21 global regions
|The Lancet Global Health|2019|1.2k
Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society
|European Heart Journal|2014|1.1k
Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment
|European Heart Journal|2015|868